Evidence map›Paper›PMID 26981498›Full record

ArticleNephro-urology monthly2016

Antiproliferative and Antioxidant Effects of Withania coagulans Extract on Benign Prostatic Hyperplasia in Rats.

Maryam Sarbishegi, Mohaddeseh Khani, Saeedeh Salimi, Mohharam Valizadeh, Fereydoon Sargolzaei Aval

Open access · hybridAbstract read
In one paragraph

Article in Nephro-urology monthly, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
8.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. The Effect ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  6. Article
  7. Nephro-urology monthly · 2016
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maryam SarbishegiDepartment of Anatomy, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran.
Mohaddeseh KhaniDepartment of Anatomy, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran.
Saeedeh SalimiCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran.
Mohharam ValizadehDepartment of Medicinal and Aromatic Plant, High Complex Education of Saravan, Saravan, IR Iran.
Fereydoon Sargolzaei AvalDepartment of Anatomy, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran.
Zahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenign prostate hyperplasia (BPH) is a common urological disorder in elderly men. Phytotherapy is frequently used to alleviate the symptoms of this condition.

objectivesThe present study investigated the effect of Withania coagulans extract (WCE), which is known to have antioxidant, anti-inflammatory, antihyperglycemic, and anti-cancer properties, on testosterone-induced BPH in rats. MATERIALS AND

methodsForty Wistar rats were divided into five groups (each n = 8): the control group, the untreated BPH group, and three WCE-treated groups (WCE250, 500, and 1000). BPH was induced with 3 mg/kg subcutaneous injections of testosterone propionate for four weeks. WCE was concomitantly administrated by oral gavage. At the end of the induction schedule, the animals were sacrificed and their prostate glands were dissected, weighed, and fixed for histological examination (H&E and proliferating cell nuclear antigen [PCNA] staining). Half of each sample was prepared for measurement of malondialdehyde (MDA) and total antioxidant capacity (TAC) levels in the prostate.

resultsThe present study revealed that BPH caused elevation of MDA levels, suppression of TAC levels, and increased PCNA expression in the prostate gland. Interestingly, in a dose-dependent manner, WCE caused decreased MDA levels and increased TAC levels in the prostate gland, compared to the untreated BPH group. Histopathological examinations showed a reduction in PCNA expression in the prostate epithelium of the WCE animals.

conclusionsW. coagulans inhibits the development of BPH can be useful for the treatment of this condition.

Indexed as

Benign Prostatic HyperplasiaProliferating Cell Nuclear Antigen, RatsWithania coagulans

Identifiers

PMID26981498
PMCPMC4779590
OpenAlexW2205909516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.